SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

HAMILTON, Bermuda and NEW YORK, Oct. 2, 2017 /PRNewswire/ -- SELLAS Life Sciences Group , Ltd. (SELLAS), a development-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today announced entry into a Cli...